Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Foundation Venture Capital Group, LLC, based in Princeton, New Jersey, specializes in impact investing within the healthcare sector. The firm focuses on pre-seed and seed funding, supporting innovative health-related startups as they move towards commercialization. They manage a portfolio of 10 companies and collaborate with local research institutions to stimulate economic development.
This firm invests in health-related technology and innovation, primarily targeting pre-seed and seed stage startups. They provide both monetary and nonmonetary support, including strategic and operational assistance. Their investment strategy emphasizes generating positive social impact while fostering a culture of innovation.
Notable companies in their portfolio include EValuate Diagnostics, Inc., which is developing a disease detection platform; Actinobac, focused on therapeutics for blood cancers; and Kayothera, which recently secured $8 million in Series A funding for cancer therapeutics. Other companies include Durin, Longevica, Zena Therapeutics, NemaGen Discoveries, NovoPedics, OculoMotor Technologies, Visikol, Inc., and MentiNova.
Email your pitch deck to jgolubieski@njhf.org for consideration.
Yes, they often lead funding rounds for the startups they invest in, particularly in the pre-seed and seed stages.
The firm is open to follow-on investments, especially for companies that demonstrate significant progress and potential for growth.
Specific fund size details are not disclosed, but they actively manage a portfolio of 10 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.